Evaluating the Safety and Efficacy of the G-stream® Drug-Eluting Stent in the Above-the-Knee Femoropopliteal Artery
A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 280 participants.
Also called NCT05780359
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 280 participants
- Registry
-
NCT05780359
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Unknown status
Technical summary
Registry record NCT05780359. Randomized; single masking; primary purpose treatment. Start 2022-05-27 (actual); primary completion 2025-06-30 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Evaluating the Safety and Efficacy of the G-stream® Drug-Eluting Stent in the Above-the-Knee Femoropopliteal Artery
- Acronym
- G-streamPAD
- Condition
- Peripheral Artery Disease
- Intervention (Device)
- Drug eluting stent
- Intervention (Device)
- drug coating balloon
- Lead sponsor
- Shenzhen Salubris Pharmaceuticals Co., Ltd.
- Collaborator
- Changhai Hospital
Record details
- Record id
cardio:ct-nct05780359- Content hash
921672fac4abb6212d05a62374200633d645e6148183494e9554ca4cc83be2e7